Literature DB >> 25461374

Live birth rate with repeat microdissection TESE and intracytoplasmic sperm injection after a conventional testicular biopsy in men with nonobstructive azoospermia.

Meric Karacan1, Murat Ulug2, Ayse Arvas2, Ziya Cebi2, Serdar Erkan2, Teksen Camlıbel2.   

Abstract

OBJECTIVE: To determine live birth rate via m-TESE and ICSI in men who had a previous conventional testicular biopsy. STUDY
DESIGN: Retrospective study was conducted to analyze 86 m-TESE procedures for ICSI in NOA patients who had a previous conventional TESE. Only motile spermatozoa were used for ICSI and all other forms were discarded. Women under the age of 42 years and who produced at least 3 oocytes in response to controlled ovarian stimulation were included in the study. Statistical significance was tested using Student's t-test, χ(2) test and Fisher's exact test as appropriate.
RESULTS: Testicular motile spermatozoa were successfully retrieved in 39 out of 47 men who had spermatozoa found in the previous biopsy (Group I), and in 6 out of 39 men with no sperm in the previous biopsy (Group II) (82.9% vs. 15.3%, respectively; p<0.01). Demographic characteristics of two groups were similar. Live birth rate per repeat m-TESE attempt via ICSI was significantly higher (23.4%, 39/47) in patients with a previous sperm-positive TESE compared to that (2.5%, 1/39) obtained in patients with a previous sperm-negative testicular biopsy (p<0.05).
CONCLUSION: Repeat attempt to obtain motile spermatozoa by m-TESE following conventional TESE ensures a higher recovery and live birth rate in men who had spermatozoa found in the first recovery procedure compared to men with no spermatozoa in the first testicular biopsy. Live birth rate through ICSI is not promising after repeat m-TESE procedure in patients with a previous sperm-negative testicular biopsy.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Azoospermia; Intracytoplasmic sperm injection; Microdissection testicular sperm extraction (m-TESE); Testicular spermatozoa

Mesh:

Year:  2014        PMID: 25461374     DOI: 10.1016/j.ejogrb.2014.10.024

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Surgically acquired sperm use for assisted reproductive technology: trends and perinatal outcomes, USA, 2004-2015.

Authors:  Jennifer F Kawwass; Jeani Chang; Sheree L Boulet; Ajay Nangia; Akanksha Mehta; Dmitry M Kissin
Journal:  J Assist Reprod Genet       Date:  2018-04-26       Impact factor: 3.412

Review 2.  Microdissection testicular sperm extraction (micro-TESE) in men with infertility due to nonobstructive azoospermia: summary of current literature.

Authors:  Arnold P P Achermann; Thairo A Pereira; Sandro C Esteves
Journal:  Int Urol Nephrol       Date:  2021-08-19       Impact factor: 2.370

3.  A clinical trial on the consistency of bilateral testicular tissue histopathology and Johnsen score: single side or bilateral side biopsy?

Authors:  Wen-Hao Tang; Shan-Jie Zhou; Shi-De Song; Hui-Ying He; Han Wu; Zhe Zhang; Yu-Zhuo Yang; Hong-Liang Zhang; Jia-Ming Mao; De-Feng Liu; Lian-Ming Zhao; Hao-Cheng Lin; Kai Hong; Lu-Lin Ma; Xin-Jie Zhuang; Hui Jiang
Journal:  Oncotarget       Date:  2018-05-08

Review 4.  Reproductive Chances of Men with Azoospermia Due to Spermatogenic Dysfunction.

Authors:  Caroline Kang; Nahid Punjani; Peter N Schlegel
Journal:  J Clin Med       Date:  2021-03-31       Impact factor: 4.241

5.  Isotretinoin for the treatment of nonobstructive azoospermia: a pilot study.

Authors:  John K Amory; Charles H Muller; Thomas J Walsh
Journal:  Asian J Androl       Date:  2021 Sep-Oct       Impact factor: 3.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.